PUBLICAÇÕES científicas

/cun/pt/investigacion/publicaciones-cientificas/areaMain/02
  • GEICO1601-ROLANDO: a multicentric single arm Phase II clinical trial to evaluate the combination of olaparib and pegylated liposomal doxorubicin for platinum-resistant ovarian cancer

    Perez-Fidalgo JA (1,1), Iglesias M (2,2), Bohn U (3,3), Calvo E (4,4), Garcia Y (5,5), Guerra E (6,6), Manso L (7,7), Santaballa A (8,8), Gonzalez-Martin A (9,9).

    (1) Department of Medical Oncology, Hospital Clinico Universitario de Valencia, CIBERONC, Spain.
    (2) Department of Medical Oncology, Hospital Universitario Son Llatzer, Palma de Mallorca, Spain.
    (3) Department of Medical Oncology, Hospital Universitario Dr Negrin, Las Palmas de Gran Canaria, Spain.
    (4) Department of Medical Oncology, Hospital Universitario Virgen del Rocio, Sevilla, Spain.
    (5) Department of Medical Oncology, Hospital Universitario Parc Tauli, Sabadell, Spain.
    (6) Department of Medical Oncology, Hospital Universitario 12 de Octubre, Madrid, Spain.
    (7) Department of Medical Oncology, Hospital Universitario Ramon y Cajal, Madrid, Spain.
    (8) Department of Medical Oncology, Hospital Politecnico y Universitario La Fe, Valencia, Spain.
    (9) Department of Medical Oncology, Clinica Universitaria de Navarra, Madrid, Spain.

    Future Science OA 10 de JANEIRO de 2019

  • Ghrelin Reduces TNF-α-Induced Human Hepatocyte Apoptosis, Autophagy, and Pyroptosis

    Ezquerro S (1,2), Mocha F (1), Frühbeck G (1,2,3), Guzmán-Ruiz R (2,4), Valentí V (2,5), Mugueta C (6), Becerril S (1,2), Catalán V (1,2), Gómez-Ambrosi J (1,2), Silva C (2,3), Salvador J (2,3), Colina I (7), Malagón MM (2,4), Rodríguez A (1,2).

    (1) Metabolic Research Laboratory, Clínica Universidad de Navarra, Pamplona, Spain.
    (2) CIBER Fisiopatología de la Obesidad y Nutrición, Instituto de Salud Carlos III, Madrid, Spain.
    (3) Department of Endocrinology & Nutrition, Clínica Universidad de Navarra, Pamplona, Spain.
    (4) Department of Cell Biology, Physiology, and Immunology, Instituto Maimónides de Investigación Biomédica, University of Córdoba, Reina Sofía University Hospital, Córdoba, Spain.
    (5) Department of Surgery, Clínica Universidad de Navarra, Pamplona, Spain.
    (6) Department of Biochemistry, Clínica Universidad de Navarra, Pamplona, Spain.
    (7) Department of Internal Medicine, Clínica Universidad de Navarra, Pamplona, Spain.

    The Journal of Clinical Endocrinology and Metabolism 01 de JANEIRO de 2019

  • Gentamicin delivery to the inner ear: Does endolymphatic hydrops matter?

    Marques P (1,2), Duan M (3,4), Perez-Fernandez N (5), Spratley J (1,2,6).

    (1) Department of Otorhinolaryngology, S.João Hospital Centre, Porto, Portugal.
    (2) Unit of Otorhinolaryngology, Department of Surgery and Physiology, University of Porto Medical School, Porto, Portugal.
    (3) Department of Clinical Science, Intervention and Technology, Karolinska Institutet, Stockholm, Sweden.
    (4) Department of Otolaryngology, Head and Neck Surgery, Karolinska Universisty Hospital, Karolinska Institutet, Stockholm, Sweden.
    (5) Department of Otorhinolaryngology, Clinica Universidad de Navarra, Madrid, Spain.
    (6) Center for Health Technology and Services Research (CINTESIS), University of Porto Medical School, Porto, Portugal.

    PLoS One 15 de NOVEMBRO de 2018

  • Gorlin Syndrome

    Palacios-Álvarez I (1), González-Sarmiento R (2), Fernández-López E (3).

    (1) Departamento de Dermatología, Clínica Universidad de Navarra, Pamplona, España.
    (2) Unidad de Medicina Molecular, Facultad de Medicina, Universidad de Salamanca, Salamanca, España; Instituto de Investigación Biomédica de Salamanca (IBSAL), Universidad de Salamanca, Salamanca, España.
    (3) Instituto de Investigación Biomédica de Salamanca (IBSAL), Universidad de Salamanca, Salamanca, España; Departamento de Dermatología, Hospital Clínico Universitario, Salamanca, España.

    Actas Dermosifiliográficas 01 de ABRIL de 2018

  • Global Forum of Cancer Surgeons: Declaration of Intent

    Are C (1,2), Coit DG (3), McMasters KM (3), Giuliano AE (3), Anderson BO (3), Balch CM (3), Pathak KA (4), Audisio RA (5), Rubio IT (5), Gonzalez-Moreno S (5), Mori M (6), Eguchi H (6), Savant D (7), Prasad BKCM (7), Cheema MA (8), Chaudhry ZA 8, Yang HK (9), Park DJ (9), Coimbra FJF (10), Quadros C (10), Said HM (11,12), Bargallo-Rocha JE (11,12).

    (1) Society of Surgical Oncology, Rosemont, IL, USA. 
    (2) Department of Surgery, University of Nebraska Medical Center, Omaha, NE, 68198, USA.
    (3) Society of Surgical Oncology, Rosemont, IL, USA.
    (4) Canadian Society of Surgical Oncology, Toronto, ON, Canada.
    (5) European Society of Surgical Oncology, Brussels, Belgium.
    (6) Japanese Society of Gastroenterological Surgery, Tokyo, Japan.
    (7) Indian Association of Surgical Oncology, Ahmedabad, India.
    (8) Pakistan Society of Surgical Oncology, Lahore, Pakistan.
    (9) Korean Society of Surgical Oncology, Goyang-si, Gyeonggi-do, South Korea.
    (10) Brazilian Society of Surgical Oncology, Salvador, Bahia, Brazil.
    (11) Sociedad Mexicana de Oncologia, Mexico City, Mexico.
    (12) Latin-American Society of Surgical Oncology, Salvador, Bahia, Brazil.

    Annals of Surgical Oncology 01 de SETEMBRO de 2017

talvezlhe interesse

QUE TECNOLOGIA UTILIZAMOS? 

A Clínica é o hospital privado com maiores recursos tecnológicos de Espanha, tudo num único centro.

Imagen de un PET, tecnología de vanguardia en la Clínica Universidad de Navarra

OS NOSSOS
PROFISSIONAIS

Os profissionais da Clínica realizam um trabalho contínuo de investigação e formação, sempre em benefício do paciente.

Imagen profesionales de la Clínica Universidad de Navarra

RAZÕES PARA VIR
À CLÍNICA

Conheça porque é que somos diferentes em relação a outros centros sanitários. Qualidade, rapidez, comodidade e resultados.

Imagen del edificio de la Clínica Universidad de Navarra